The results demonstrate phase 1 trials help filter out unsafe or ineffective drugs, investigators concluded. Jonathan Kimmelman, PhD, has published multiple research papers and gotten into an ...

CHICAGO, IL / ACCESS Newswire / April 16, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome a leading ...

SRMJEE 2025 Phase 1 application for admissions into B.Tech courses in various SRM colleges ends today, April 16, 2025. Interested and eligible candidates can apply through the official website of ...

EVANS, Colo., April 29, 2025 /PRNewswire/ -- Vero Fiber is proud to announce the completion of Phase 1 of its fiber internet construction project in the City of Evans, bringing fast, reliable ...

That includes the district’s long-range facilities plan which is nearing the end of Phase 1 and now the district is beginning to plan for Phase 2. About three years ago, the district began ...

On April 15, 2025, MetaVia Inc. (NASDAQ:MTVA) announced positive results from the Phase 1 Part 2 multiple ascending dose (MAD) trial of DA-1726 in obesity. The results showed that the cohort ...

LITTLE ROCK (KATV) — Pulaski County is set to announce the completion of Phase 1 of the Southwest Trail this morning, government officials said in a release. The Southwest Trail is a planned 65 ...

LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02.

About the CHS-114 Phase 1 Study The Phase 1 study (NCT05635643) is a dose escalation, dose optimization, and expansion study evaluating CHS-114 as a monotherapy and in combination with toripalimab ...

SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it completed enrollment of its Phase 1 clinical trial evaluating its second-generation ...

The topline results are from ACHIEVE-1, the first phase III trial of an oral GLP-1 drug to successfully reach completion, a press release notes. Taken as a once-daily pill, orforglipron, unlike oral ...

We are very excited to begin dosing patients in our Phase 1/2 clinical study of OBI-902 later this year.” 1 OBI-902, a novel TROP-2 targeted antibody-drug conjugate via GlycOBI ® platform, has ...